Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference48 articles.
1. Rotschafer JC, Shikuma LR. Pseudomonas aeruginosa susceptibility in a university hospital: recognition and treatment. Drug Intell Clin Pharm. 1986;20:575–81.
2. Parkins MD, Somayaji R, Waters VJ. Epidemiology, biology, and impact of clonal pseudomonas aeruginosa infections in cystic fibrosis. Clin Microbiol Rev. 2018;31:e00019–18.
3. World Health Organization. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis; World Health Organization: Geneva, Switzerland, 2017.
4. National Nosocomial Infections Surveillance (NNIS). System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85.
5. Dou Y, Huan J, Guo F, Zhou Z, Shi Y. Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014. J Int Med Res. 2017;45:1124–37.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献